Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2023

26-08-2023 | Atropine | Original Article

Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT3 and Dopamine D2 Receptors in Mice

Authors: Hiroshi Satoh, Yasutada Akiba, Tetsuro Urushidani, Jonathan D. Kaunitz

Published in: Digestive Diseases and Sciences | Issue 10/2023

Login to get access

Abstract

Background/Aims

We examined the contributions of gastric emptying and duodenogastric bile reflux in the formation of gastric antral ulcers induced by NSAIDs in mice.

Methods

We used the murine re-fed indomethacin (IND) experimental ulcer model. Outcome measures included the appearance of gastric lesions 24 h after IND treatment and the assessment of gastric contents and the concentration of bile acids 1.5 h after re-feeding. The effects of atropine, dopamine, SR57227 (5-HT3 receptor agonist), apomorphine, ondansetron, haloperidol, and dietary taurocholate and cholestyramine were also examined.

Results

IND (10 mg/kg, s.c.) induced severe lesions only in the gastric antrum in the re-fed model. The antral lesion index and the amount of food intake during the 2-h refeeding period were positively correlated. Atropine and dopamine delayed gastric emptying, increased bile reflux, and worsened IND-induced antral lesions. SR57227 and apomorphine worsened antral lesions with increased bile reflux. These effects were prevented by the anti-emetic drugs ondansetron and haloperidol, respectively. The anti-emetic drugs markedly decreased the severity of antral lesions and the increase of bile reflux induced by atropine or dopamine without affecting delayed gastric emptying. Antral lesions induced by IND were increased by dietary taurocholate but decreased by the addition of the bile acid sequestrant cholestyramine.

Conclusions

These results suggest that gastroparesis induced by atropine or dopamine worsens NSAID-induced gastric antral ulcers by increasing duodenogastric bile reflux via activation of 5-HT3 and dopamine D2 receptors.
Literature
1.
go back to reference Taylor RT, Huskisson EC, Whitehouse GH, Hart FD, Trapnell DH. Gastric ulceration occurring during indomethacin therapy. Br Med J 1968;4:734–737.PubMedCrossRef Taylor RT, Huskisson EC, Whitehouse GH, Hart FD, Trapnell DH. Gastric ulceration occurring during indomethacin therapy. Br Med J 1968;4:734–737.PubMedCrossRef
2.
go back to reference Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. . Arch Intern Med 1987;147:2093–2100.PubMedCrossRef Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. . Arch Intern Med 1987;147:2093–2100.PubMedCrossRef
4.
go back to reference McCarthy DM. Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 1989;96:662–674.PubMedCrossRef McCarthy DM. Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 1989;96:662–674.PubMedCrossRef
5.
go back to reference Satoh H, Urushidani T. Soluble dietary fiber can protect the gastrointestinal mucosa against nonsteroidal anti-inflammatory drugs in mice. Dig Dis Sci 2016;61:1903–1914.PubMedCrossRef Satoh H, Urushidani T. Soluble dietary fiber can protect the gastrointestinal mucosa against nonsteroidal anti-inflammatory drugs in mice. Dig Dis Sci 2016;61:1903–1914.PubMedCrossRef
6.
go back to reference Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-associated gastric ulcer study group. Arch Intern Med 2000;160:1455–1461.PubMedCrossRef Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-associated gastric ulcer study group. Arch Intern Med 2000;160:1455–1461.PubMedCrossRef
7.
go back to reference Campbell DR, Haber MM, Sheldon E et al. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine. Am J Gastroenterol 2002;97:2208–2214.PubMedCrossRef Campbell DR, Haber MM, Sheldon E et al. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine. Am J Gastroenterol 2002;97:2208–2214.PubMedCrossRef
8.
go back to reference Yeomans ND, Svedberg LE, Naesdal J. Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? Int J Clin Pract 2006;60:1401–1407.PubMedCrossRef Yeomans ND, Svedberg LE, Naesdal J. Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? Int J Clin Pract 2006;60:1401–1407.PubMedCrossRef
9.
go back to reference Satoh H, Akiba Y, Urushidani T. Proton pump inhibitors prevent gastric antral ulcers induced by NSAIDs via activation of capsaicin-sensitive afferent nerves in mice. Dig Dis Sci 2020;65:2580–2594.PubMedCrossRef Satoh H, Akiba Y, Urushidani T. Proton pump inhibitors prevent gastric antral ulcers induced by NSAIDs via activation of capsaicin-sensitive afferent nerves in mice. Dig Dis Sci 2020;65:2580–2594.PubMedCrossRef
10.
go back to reference Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986;31:1114–1122.PubMedCrossRef Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986;31:1114–1122.PubMedCrossRef
11.
go back to reference Ueki S, Takeuchi K, Okabe S. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 1988;33:209–216.PubMedCrossRef Ueki S, Takeuchi K, Okabe S. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 1988;33:209–216.PubMedCrossRef
12.
go back to reference Müller-Lissner SA, Fimmel CJ, Sonnenberg A et al. Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut 1983;24:510–518.PubMedPubMedCentralCrossRef Müller-Lissner SA, Fimmel CJ, Sonnenberg A et al. Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut 1983;24:510–518.PubMedPubMedCentralCrossRef
13.
go back to reference Sonnenberg A, Müller-Lissner SA, Schattenmann G, Siewert JR, Blum AL. Duodenogastric reflux in the dog. Am J Physiol 1982;242:G603–G607.PubMed Sonnenberg A, Müller-Lissner SA, Schattenmann G, Siewert JR, Blum AL. Duodenogastric reflux in the dog. Am J Physiol 1982;242:G603–G607.PubMed
14.
go back to reference Davenport HW. Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 1968;54:175–181.PubMedCrossRef Davenport HW. Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 1968;54:175–181.PubMedCrossRef
16.
go back to reference Armstrong D, Rytina ER, Murphy GM, Dowling RH. Gastric mucosal toxicity of duodenal juice constituents in the rat. Acute studies using ex vivo rat gastric chamber model. Dig Dis Sci 1994;39:327–339.PubMedCrossRef Armstrong D, Rytina ER, Murphy GM, Dowling RH. Gastric mucosal toxicity of duodenal juice constituents in the rat. Acute studies using ex vivo rat gastric chamber model. Dig Dis Sci 1994;39:327–339.PubMedCrossRef
17.
go back to reference Nagahata Y, Azumi Y, Kawakita N, Wada T, Saitoh Y. Inhibitory effect of dopamine on gastric motility in rats. Scand J Gastroenterol 1995;30:880–885.PubMedCrossRef Nagahata Y, Azumi Y, Kawakita N, Wada T, Saitoh Y. Inhibitory effect of dopamine on gastric motility in rats. Scand J Gastroenterol 1995;30:880–885.PubMedCrossRef
18.
go back to reference Levein NG, Thörn SE, Wattwil M. Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers. Eur J Anaesthesiol 1999;16:246–250.PubMedCrossRef Levein NG, Thörn SE, Wattwil M. Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers. Eur J Anaesthesiol 1999;16:246–250.PubMedCrossRef
20.
go back to reference Tack J, Camilleri M. New developments in the treatment of gastroparesis and functional dyspepsia. Curr Opin Pharmacol 2018;43:111–117.PubMedCrossRef Tack J, Camilleri M. New developments in the treatment of gastroparesis and functional dyspepsia. Curr Opin Pharmacol 2018;43:111–117.PubMedCrossRef
21.
go back to reference Feinle C, Read NW. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility. Am J Physiol 1996;271:G591–G597.PubMed Feinle C, Read NW. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility. Am J Physiol 1996;271:G591–G597.PubMed
22.
go back to reference Sanger GJ, Andrews PLR. A history of drug discovery for treatment of nausea and vomiting and the implications for future research. Front Pharmacol 2018;9:913.PubMedPubMedCentralCrossRef Sanger GJ, Andrews PLR. A history of drug discovery for treatment of nausea and vomiting and the implications for future research. Front Pharmacol 2018;9:913.PubMedPubMedCentralCrossRef
23.
go back to reference Parthasarathy G, Ravi K, Camilleri M et al. Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. Neurogastroenterol Motil 2015;27:1736–1746.PubMedPubMedCentralCrossRef Parthasarathy G, Ravi K, Camilleri M et al. Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. Neurogastroenterol Motil 2015;27:1736–1746.PubMedPubMedCentralCrossRef
24.
go back to reference Uchida M, Yamato S, Shimizu K, Amano T, Ariga H. Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats. J Pharmacol Sci 2013;121:282–287.PubMedCrossRef Uchida M, Yamato S, Shimizu K, Amano T, Ariga H. Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats. J Pharmacol Sci 2013;121:282–287.PubMedCrossRef
25.
go back to reference Seto Y, Yoshida N, Kaneko H. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats. J Pharmacol Sci 2011;116:47–53.PubMedCrossRef Seto Y, Yoshida N, Kaneko H. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats. J Pharmacol Sci 2011;116:47–53.PubMedCrossRef
26.
go back to reference Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M. Direct spectrophotometry of total bile acids in serum. Clin Chem 1981;27:1352–1356.PubMedCrossRef Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M. Direct spectrophotometry of total bile acids in serum. Clin Chem 1981;27:1352–1356.PubMedCrossRef
27.
go back to reference Bachy A, Héaulme M, Giudice A et al. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. Eur J Pharmacol 1993;237:299–309.PubMedCrossRef Bachy A, Héaulme M, Giudice A et al. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. Eur J Pharmacol 1993;237:299–309.PubMedCrossRef
28.
go back to reference Depoortère R, Barret-Grévoz C, Bardin L, Newman-Tancredi A. Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT1A antipsychotic compounds. Eur J Pharmacol 2008;597:34–38.PubMedCrossRef Depoortère R, Barret-Grévoz C, Bardin L, Newman-Tancredi A. Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT1A antipsychotic compounds. Eur J Pharmacol 2008;597:34–38.PubMedCrossRef
29.
go back to reference Markham A, Sorkin EM. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs 1993;45:931–952.PubMedCrossRef Markham A, Sorkin EM. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs 1993;45:931–952.PubMedCrossRef
30.
go back to reference Schwalbe T, Kaindl J, Hübner H, Gmeiner P. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor. Bioorg Med Chem 2017;25:5084–5094.PubMedCrossRef Schwalbe T, Kaindl J, Hübner H, Gmeiner P. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor. Bioorg Med Chem 2017;25:5084–5094.PubMedCrossRef
31.
32.
go back to reference Gotthard R, Bodemar G, Tjädermo M, Tobiasson P, Walan A. High gastric bile acid concentration in prepyloric ulcer patients. Scand J Gastroenterol 1985;20:439–446.PubMedCrossRef Gotthard R, Bodemar G, Tjädermo M, Tobiasson P, Walan A. High gastric bile acid concentration in prepyloric ulcer patients. Scand J Gastroenterol 1985;20:439–446.PubMedCrossRef
33.
go back to reference Rydning A, Berstad A. Intragastric bile acid concentrations in healthy subjects and in patients with gastric and duodenal ulcer and the influence of fiber-enriched wheat bran in patients with gastric ulcer. Scand J Gastroenterol 1985;20:801–804.PubMedCrossRef Rydning A, Berstad A. Intragastric bile acid concentrations in healthy subjects and in patients with gastric and duodenal ulcer and the influence of fiber-enriched wheat bran in patients with gastric ulcer. Scand J Gastroenterol 1985;20:801–804.PubMedCrossRef
35.
go back to reference Rhodes J, Barnardo DE, Phillips SF, Rovelstad RA, Hofmann AF. Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology 1969;57:241–252.PubMedCrossRef Rhodes J, Barnardo DE, Phillips SF, Rovelstad RA, Hofmann AF. Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology 1969;57:241–252.PubMedCrossRef
36.
go back to reference Yokoyama M, Tatsuta M, Baba M, Kitamura Y. Bile reflux: a possible cause of stomach ulcer in nontreated mutant mice of W/Wv genotype. Gastroenterology 1982;82:857–863.PubMedCrossRef Yokoyama M, Tatsuta M, Baba M, Kitamura Y. Bile reflux: a possible cause of stomach ulcer in nontreated mutant mice of W/Wv genotype. Gastroenterology 1982;82:857–863.PubMedCrossRef
37.
go back to reference Azuma T, Dojyo M, Ito S et al. Bile reflux due to disturbed gastric movement is a cause of spontaneous gastric ulcer in W/Wv mice. Dig Dis Sci 1999;44:1177–1183.PubMedCrossRef Azuma T, Dojyo M, Ito S et al. Bile reflux due to disturbed gastric movement is a cause of spontaneous gastric ulcer in W/Wv mice. Dig Dis Sci 1999;44:1177–1183.PubMedCrossRef
38.
go back to reference Silen W, Forte JG. Effects of bile salts on amphibian gastric mucosa. Am J Physiol 1975;228:637–644.PubMedCrossRef Silen W, Forte JG. Effects of bile salts on amphibian gastric mucosa. Am J Physiol 1975;228:637–644.PubMedCrossRef
39.
go back to reference Schindlbeck NE, Heinrich C, Stellaard F, Paumgartner G, Müller-Lissner SA. Healthy controls have as much bile reflux as gastric ulcer patients. Gut 1987;28:1577–1583.PubMedPubMedCentralCrossRef Schindlbeck NE, Heinrich C, Stellaard F, Paumgartner G, Müller-Lissner SA. Healthy controls have as much bile reflux as gastric ulcer patients. Gut 1987;28:1577–1583.PubMedPubMedCentralCrossRef
40.
go back to reference Li D, Zhang J, Yao WZ et al. The relationship between gastric cancer, its precancerous lesions and bile reflux: a retrospective study. J Dig Dis 2020;21:222–229.PubMedPubMedCentralCrossRef Li D, Zhang J, Yao WZ et al. The relationship between gastric cancer, its precancerous lesions and bile reflux: a retrospective study. J Dig Dis 2020;21:222–229.PubMedPubMedCentralCrossRef
44.
45.
go back to reference Belkacemi L, Darmani NA. Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function. Pharmacol Res 2020;161:105–124.CrossRef Belkacemi L, Darmani NA. Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function. Pharmacol Res 2020;161:105–124.CrossRef
46.
go back to reference Currò D, Ipavec V, Preziosi P. Neurotransmitters of the non-adrenergic non-cholinergic relaxation of proximal stomach. Eur Rev Med Pharmacol Sci 2008;12:53–62.PubMed Currò D, Ipavec V, Preziosi P. Neurotransmitters of the non-adrenergic non-cholinergic relaxation of proximal stomach. Eur Rev Med Pharmacol Sci 2008;12:53–62.PubMed
47.
go back to reference Glatzle J, Sternini C, Robin C et al. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 2002;123:217–226.PubMedCrossRef Glatzle J, Sternini C, Robin C et al. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 2002;123:217–226.PubMedCrossRef
48.
go back to reference Minami M, Endo T, Hirafuji M et al. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol Ther 2003;99:149–165.PubMedCrossRef Minami M, Endo T, Hirafuji M et al. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol Ther 2003;99:149–165.PubMedCrossRef
49.
go back to reference Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion 2002;66:30–41.PubMedCrossRef Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion 2002;66:30–41.PubMedCrossRef
50.
go back to reference Akiba Y, Maruta K, Narimatsu K et al. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats. Am J Physiol Gastrointest Liver Physiol 2017;313:G117–G128.PubMedPubMedCentralCrossRef Akiba Y, Maruta K, Narimatsu K et al. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats. Am J Physiol Gastrointest Liver Physiol 2017;313:G117–G128.PubMedPubMedCentralCrossRef
Metadata
Title
Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT3 and Dopamine D2 Receptors in Mice
Authors
Hiroshi Satoh
Yasutada Akiba
Tetsuro Urushidani
Jonathan D. Kaunitz
Publication date
26-08-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08086-x

Other articles of this Issue 10/2023

Digestive Diseases and Sciences 10/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.